Functional Genomics of Chemical-Induced Acute Lung Injury
Functional Genomics of Chemical-Induced Acute Lung Injury
批准号:
8694032
负责人:
George Douglas Leikauf
金额:
$71.55万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-09-29 至 2016-04-30
关键词:
AKT1 geneAcroleinAcuteAcute Lung InjuryAddressAmmoniaCandidate Disease GeneCaringCell DeathCell SurvivalCellsCessation of lifeChemicalsChlorineChromosomes, Human, Pair 10DiagnosisEpithelialEventExposure toFundingGene ProteinsGene TargetingHomologous GeneHourHumanIn VitroInhalation ExposureIntramuscularIntraperitoneal InjectionsLeadLinkLungMalignant NeoplasmsMethodsMolecularMouse StrainsMusPTEN genePathologyPhenanthrolinesPhosgenePhosphoric Monoester HydrolasesPlantsPotassiumPrincipal InvestigatorProteinsPulmonary EdemaRailroadsResearchResistanceRespiratory FailureRoleSignal TransductionSigns and SymptomsSmall Interfering RNAStructure of respiratory epitheliumSulfuric AcidsSupportive careTestingTherapeuticThymomaTimeToxic effectViral OncogeneWorkbasebisperoxo(1,10-phenanthroline)oxovanadate(1-)chemical additionchemical threatcytotoxicityfunctional genomicsimprovedin vivoinhibitor/antagonistlung injurymortalitymouse modelprotein protein interactionpublic health relevancerepairedscreeningsmall moleculesmall molecule libraries
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Chemical-induced acute lung injury (CIALI) can result from numerous chemical threats that avail themselves to terrorist attacks. Therapies are needed to treat the acute effects and pathologies that are common to several chemical threat agents. Despite intensive effort, much remains to be understood regarding pathological events linking Inhalation exposures to delayed pulmonary edema, respiratory failure, and ultimately death. In past funding period we developed and validated mouse models of acute lung injury to 5 common chemicals (acrolein, ammonia, chlorine, phosgene, and sulfuric acid). Using a functional genomics approach, 40 mouse strains were used to identify candidate genes associated with survival time following exposure. We combined the results to build a protein interaction network (interactome). Within this network, a cell signaling hub (i.e. a protein with several protein-protein interactions) was uncovered that implicated v- AKT1 thymoma viral oncogene homolog 1 (AKT1). When phosphorylated, AKT1 enhances survival by inactivating components of the cell death machinery. Although undesirable in cancer, we reasoned that short-term, reversible enhancement of the cell survival AKT1 activity could be beneficial in CIALI treatment. We subsequently found that inhibition of phosphatase and tensin homolog deleted on chromosome 10 (PTEN), a phosphatase that limits AKT1 activity, enhances epithelial repair in vitro and protect against CIALI in vivo. Hypothesis: Inhibition of PTEN activity will impart resistance to CIALI by activating signaling events that promote cell survival. Approach: Using a high content screening method, lead compounds [including a PTEN inhibitor] will be administered in vitro to test reverse of lethality in target cells. Lead compounds will be tested in mouse models of lethality from CIALI with 5 chemicals. Overall Objective: To develop a therapy that improves survival during lung injury induced by multiple chemicals.
Public Health Relevance: Acute lung injury can result from numerous chemical threats that avail themselves to terrorist attacks. Current therapy remains limited to supportive care with no approved therapeutic for post insult treatment. The overall objective is to develop a therapy that will improve survival during acute lung injury induced by more than one chemical.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pathophysiological Mechanisms of Chemical-Induced Acute Lung Injury
-
批准号:10708438
-
项目类别:
-
资助金额:$49.93万
-
财政年份:2023
-
负责人:George Douglas Leikauf
-
依托单位:
Improving our mechanistic understanding of Electronic-cigarette, or vaping, product use-associated lung injury
-
批准号:10115186
-
项目类别:
-
资助金额:$11.97万
-
财政年份:2020
-
负责人:George Douglas Leikauf
-
依托单位:
Countermeasure Therapeutics for Acute Lung Injury
-
批准号:9207983
-
项目类别:
-
资助金额:$23.14万
-
财政年份:2016
-
负责人:George Douglas Leikauf
-
依托单位:
Countermeasure Therapeutics for Acute Lung Injury
-
批准号:9357593
-
项目类别:
-
资助金额:$19.46万
-
财政年份:2016
-
负责人:George Douglas Leikauf
-
依托单位:
Role of Metalloproteinases in Mucin Overproduction in COPD
-
批准号:7461274
-
项目类别:
-
资助金额:$35.32万
-
财政年份:2008
-
负责人:George Douglas Leikauf
-
依托单位:
Role of Metalloproteinases in Mucin Overproduction in COPD
-
批准号:7783818
-
项目类别:
-
资助金额:$34.2万
-
财政年份:2008
-
负责人:George Douglas Leikauf
-
依托单位:
Role of Metalloproteinases in Mucin Overproduction in COPD
-
批准号:7581036
-
项目类别:
-
资助金额:$34.2万
-
财政年份:2008
-
负责人:George Douglas Leikauf
-
依托单位:
Functional Genomics of Chemical-Induced Acute Lung Injury
-
批准号:8144632
-
项目类别:
-
资助金额:$75.33万
-
财政年份:2006
-
负责人:George Douglas Leikauf
-
依托单位:
Functional Genomics of Chemical-Induced Acute Lung Injury
-
批准号:8323241
-
项目类别:
-
资助金额:$74.44万
-
财政年份:2006
-
负责人:George Douglas Leikauf
-
依托单位:
Functional Genomics of Chemical-Induced Acute Lung Injury
-
批准号:8485604
-
项目类别:
-
资助金额:$73.0万
-
财政年份:2006
-
负责人:George Douglas Leikauf
-
依托单位:
Functional Genomics of Chemical -Induced Acute Lung Injury
-
批准号:7662563
-
项目类别:
-
资助金额:$70.5万
-
财政年份:2006
-
负责人:George Douglas Leikauf
-
依托单位:
Functional Genomics of Chemical -Induced Acute Lung Injury
-
批准号:7498521
-
项目类别:
-
资助金额:$68.94万
-
财政年份:2006
-
负责人:George Douglas Leikauf
-
依托单位:
Functional Genomics of Chemical -Induced Acute Lung Injury
-
批准号:7293573
-
项目类别:
-
资助金额:$73.86万
-
财政年份:2006
-
负责人:George Douglas Leikauf
-
依托单位:
Functional Genomics of Chemical-Induced Acute Lung Injury
-
批准号:8901168
-
项目类别:
-
资助金额:$69.95万
-
财政年份:2006
-
负责人:George Douglas Leikauf
-
依托单位:
Functional Genomics of Chemical -Induced Acute Lung Injury
-
批准号:7224694
-
项目类别:
-
资助金额:$77.22万
-
财政年份:2006
-
负责人:George Douglas Leikauf
-
依托单位:
Functional Genomics of Chemical -Induced Acute Lung Injury
-
批准号:7858079
-
项目类别:
-
资助金额:$71.4万
-
财政年份:2006
-
负责人:George Douglas Leikauf
-
依托单位:
Growth Factor Protection in Acute Lung Injury
-
批准号:7159406
-
项目类别:
-
资助金额:$34.76万
-
财政年份:2005
-
负责人:George Douglas Leikauf
-
依托单位:
Growth Factor Protection in Acute Lung Injury
-
批准号:7535986
-
项目类别:
-
资助金额:$32.8万
-
财政年份:2005
-
负责人:George Douglas Leikauf
-
依托单位:
Growth Factor Protection in Acute Lung Injury
-
批准号:7049989
-
项目类别:
-
资助金额:$35.98万
-
财政年份:2005
-
负责人:George Douglas Leikauf
-
依托单位:
Growth Factor Protection in Acute Lung Injury
-
批准号:7329821
-
项目类别:
-
资助金额:$35.73万
-
财政年份:2005
-
负责人:George Douglas Leikauf
-
依托单位:
国内基金
海外基金
Acrolein调控耳蜗核神经元-胶质细胞网络参与感音神经性耳聋发病机制的研究
-
批准号:81570922
-
项目类别:面上项目
-
资助金额:65.0万元
-
批准年份:2015
-
负责人:屈涓
-
依托单位:
acrolein在脊髓损伤后慢性疼痛发生发展中的作用及机制研究
-
批准号:81171052
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:武胜昔
-
依托单位: